Bausch Health Companies Inc.

Bausch Health Companies Inc. is a global American-Canadian pharmaceutical industry.

Headquarters

It's international headquarters are located in Laval, Quebec, and its American headquarters are in Bridgewater, New Jersey.

Products

The company creates and markets many pharmaceutical products in gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health makes and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products in more than 90 countries and regions, including the United States, Canada, Europe, Middle East, Africa, Asia Pacific and Latin America.[1]

History

In 1959, Milan Panić founded ICN Pharmaceuticals. Panić ran the company for 43 years. In 1994, ICN merged with SPI Pharmaceuticals Inc., Viratek Inc., and ICN Biomedicals Inc.[2] In 2003, ICN Pharmaceuticals changed its name to Valeant Pharmaceuticals.[3] In 2017, Valeant sold 3 of it's skin care brands (CeraVe, Acnefree, and AMBI) to L'Oréal.[4][5] Then, in 2018, it changed it's name again into Bausch Health Companies Inc.[6][7][8]

References

  1. ↑ "About Us: Who We Are". Bausch Health Companies Inc. Retrieved 13 May 2025.
  2. ↑ "Shareholders Approve ICN Pharmaceuticals Merger". The New York Times. November 3, 1994.
  3. ↑ "ICN Pharmaceuticals, Inc. Changes Its Name To Valeant Pharmaceuticals International" (Press release). PRNewswire. November 12, 2003. Archived from the original on April 9, 2016. Retrieved March 28, 2016.
  4. ↑ "Valeant Pharmaceuticals sells 3 of its products to L'Oreal | Globalnews.ca". Global News. Retrieved 2025-07-11.
  5. ↑ "Valeant sells 3 skincare brands to L'Oréal for $1.3B". CNBC. 2017-01-10. Retrieved 2025-07-11.
  6. ↑ "Valeant Will Become Bausch Health Companies Inc". ir.bauschhealth.com. Retrieved 2025-07-11.
  7. ↑ "Valeant to Change its Name to Bausch Health Companies, Reports Loss in First Quarter". BioSpace. 2018-05-08. Retrieved 2025-07-11.
  8. ↑ Grant, Charley (2018-05-08). "A Valeant Rebranding". Wall Street Journal. ISSN 0099-9660. Retrieved 2025-07-11.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.